These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8092840)

  • 21. Active-Site Protonation States in an Acyl-Enzyme Intermediate of a Class A β-Lactamase with a Monobactam Substrate.
    Vandavasi VG; Langan PS; Weiss KL; Parks JM; Cooper JB; Ginell SL; Coates L
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel, plasmid-encoded, TEM-derived extended-spectrum beta-lactamase in Klebsiella pneumoniae conferring higher resistance to aztreonam than to extended-spectrum cephalosporins.
    Arlet G; Rouveau M; Fournier G; Lagrange PH; Philippon A
    Antimicrob Agents Chemother; 1993 Sep; 37(9):2020-3. PubMed ID: 8239625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Replacement of serine 237 in class A beta-lactamase of Proteus vulgaris modifies its unique substrate specificity.
    Tamaki M; Nukaga M; Sawai T
    Biochemistry; 1994 Aug; 33(33):10200-6. PubMed ID: 8060986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A survey of a functional amino acid of class C beta-lactamase corresponding to Glu166 of class A beta-lactamases.
    Nukaga M; Tanimoto K; Tsukamoto K; Imajo S; Ishiguro M; Sawai T
    FEBS Lett; 1993 Oct; 332(1-2):93-8. PubMed ID: 8104827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ceftazidime and aztreonam resistance in Providencia stuartii: characterization of a natural TEM-derived extended-spectrum beta-lactamase, TEM-60.
    Franceschini N; Perilli M; Segatore B; Setacci D; Amicosante G; Mazzariol A; Cornaglia G
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1459-62. PubMed ID: 9624494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Properties of a broad spectrum beta-lactamase isolated from Flavobacterium meningosepticum GN14059.
    Fujii T; Sato K; Yokota E; Maejima T; Inoue M; Mitsuhashi S
    J Antibiot (Tokyo); 1988 Jan; 41(1):81-5. PubMed ID: 3257961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects on substrate profile by mutational substitutions at positions 164 and 179 of the class A TEM(pUC19) beta-lactamase from Escherichia coli.
    Vakulenko SB; Taibi-Tronche P; Tóth M; Massova I; Lerner SA; Mobashery S
    J Biol Chem; 1999 Aug; 274(33):23052-60. PubMed ID: 10438473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TEM-184, a Novel TEM-Derived Extended-Spectrum β-Lactamase with Enhanced Activity against Aztreonam.
    Piccirilli A; Perilli M; Amicosante G; Conte V; Tascini C; Rossolini GM; Giani T
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resistance caused by decreased penetration of beta-lactam antibiotics into Enterobacter cloacae.
    Bush K; Tanaka SK; Bonner DP; Sykes RB
    Antimicrob Agents Chemother; 1985 Apr; 27(4):555-60. PubMed ID: 3873900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of AmpC beta-lactamase through a destabilizing interaction in the active site.
    Trehan I; Beadle BM; Shoichet BK
    Biochemistry; 2001 Jul; 40(27):7992-9. PubMed ID: 11434768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deciphering the Evolution of Cephalosporin Resistance to Ceftolozane-Tazobactam in Pseudomonas aeruginosa.
    Barnes MD; Taracila MA; Rutter JD; Bethel CR; Galdadas I; Hujer AM; Caselli E; Prati F; Dekker JP; Papp-Wallace KM; Haider S; Bonomo RA
    mBio; 2018 Dec; 9(6):. PubMed ID: 30538183
    [No Abstract]   [Full Text] [Related]  

  • 32. Plasmid-mediated beta-lactamase (TEM-7) involved in resistance to ceftazidime and aztreonam.
    Gutmann L; Kitzis MD; Billot-Klein D; Goldstein F; Tran Van Nhieu G; Lu T; Carlet J; Collatz E; Williamson R
    Rev Infect Dis; 1988; 10(4):860-6. PubMed ID: 3055178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial resistance and prevalence of extended spectrum beta-lactamase among clinical isolates of gram-negative bacteria in Riyadh.
    El-Karsh T; Tawfik AF; Al-Shammary F; Al-Salah S; Kambal AM; Shibl AM
    J Chemother; 1995 Dec; 7(6):509-14. PubMed ID: 8667034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetic characterization of GES-22 β-lactamase harboring the M169L clinical mutation.
    Saral A; Leonard DA; Duzgun AO; Cicek AC; June CM; Sandalli C
    J Antibiot (Tokyo); 2016 Dec; 69(12):858-862. PubMed ID: 27168312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New Delhi metallo-β-lactamase (NDM-1): an update.
    Shakil S; Azhar EI; Tabrez S; Kamal MA; Jabir NR; Abuzenadah AM; Damanhouri GA; Alam Q
    J Chemother; 2011 Oct; 23(5):263-5. PubMed ID: 22005056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Identification of a cephalosporinase susceptible to clavulanic acid in a clinical strain of Serratia fonticola].
    Farzaneh S; Péduzzi J; Demachy MC; Barthélémy M; Labia R
    Pathol Biol (Paris); 1995 Apr; 43(4):315-9. PubMed ID: 7567122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive analysis of ceftazidime hydrolysis in CTX-M-type beta-lactamase family members with a mutational substitution at position 167.
    Kimura S; Ishii Y; Tateda K; Yamaguchi K
    Int J Antimicrob Agents; 2007 Mar; 29(3):326-31. PubMed ID: 17258896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum beta-lactamase encoded by an Escherichia coli integron gene.
    Poirel L; Naas T; Guibert M; Chaibi EB; Labia R; Nordmann P
    Antimicrob Agents Chemother; 1999 Mar; 43(3):573-81. PubMed ID: 10049269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of azthreonam and related monobactams with beta-lactamases from gram-negative bacteria.
    Bush K; Freudenberger JS; Sykes RB
    Antimicrob Agents Chemother; 1982 Sep; 22(3):414-20. PubMed ID: 6982680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of substitution of Asn for Arg-276 in the cefotaxime-hydrolyzing class A beta-lactamase CTX-M-4.
    Gazouli M; Legakis NJ; Tzouvelekis LS
    FEMS Microbiol Lett; 1998 Dec; 169(2):289-93. PubMed ID: 9868772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.